{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P00813",
      "entity_text" : "ADA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "Organ" : [ "uberon:UBERON:0007023" ]
    }
  },
  "verbose_text" : "(ACCF / AHA Class III, Level of Evidence C) (ADA Level of Evidence C) Low-dose (75-162 mg/day) aspirin use for prevention might be considered for those with diabetes at intermediate CVD risk (younger patients with one or more risk factors, or older patients with no risk factors, or patients with 10-year CVD risk of 5-10%) until further research is available.",
  "reading_complete" : "2020-07-28T17:22:27Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T17:20:31Z",
  "trigger" : "Level",
  "evidence" : [ "ADA Level" ],
  "pmc_id" : "2875463",
  "score" : 0
}